Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of RARE would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2014) — listing | $8,291 0.4× | $12,099 0.4× |
| Year 6 (2019) | $5,421 0.5× | $7,893 0.5× |
| Year 11 (2024) | $2,376 0.7× | $3,478 0.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Novato, California, United States
Popular scenarios with RARE
For illustration only — not investment advice. Past performance is not indicative of future results.